BioTime announced plan to spin-off AgeX Therapeutics. The separation is expected to occur during the end of September 2018. Spin-Off Research, founded by Joe Cornell, has tracked and provided analysis on Spin-Offs since 1997. Spin-Off Research is the market leader in Spin-Off valuation.
BioTime announced plan to spin-off AgeX Therapeutics. The separation is expected to occur during the end of September 2018. Spin-Off Research, founded by Joe Cornell, has tracked and provided analysis on Spin-Offs since 1997. Spin-Off Research is the market leader in Spin-Off valuation.
Share this Article
Recommended